Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | 6,717,000 | 6,552,000 | 5,893,000 | 7,264,000 | 7,842,000 |
Depreciation Amortization | 4,071,000 | 3,417,000 | 3,398,000 | 3,601,000 | 2,206,000 |
Income taxes - deferred | -1,273,000 | -1,198,000 | -453,000 | -287,000 | -289,000 |
Accounts receivable | -1,015,000 | -746,000 | -429,000 | -427,000 | -504,000 |
Accounts payable and accrued liabilities | -402,000 | 154,000 | -69,000 | 45,000 | 164,000 |
Other Working Capital | -484,000 | -733,000 | -1,194,000 | -216,000 | -731,000 |
Other Operating Activity | 857,000 | 2,275,000 | 2,115,000 | 517,000 | 462,000 |
Operating Cash Flow | $8,471,000 | $9,721,000 | $9,261,000 | $10,497,000 | $9,150,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 1,672,000 | -1,369,000 | 4,334,000 | -1,499,000 | 19,996,000 |
PPE Investments | -1,112,000 | -936,000 | -880,000 | -608,000 | -618,000 |
Net Acquisitions | -26,989,000 | -3,839,000 | -2,529,000 | N/A | -13,617,000 |
Purchase Of Investment | N/A | N/A | N/A | -3,219,000 | -24,000 |
Other Investing Activity | 225,000 | 100,000 | -192,000 | -75,000 | -28,000 |
Investing Cash Flow | $-26,204,000 | $-6,044,000 | $733,000 | $-5,401,000 | $5,709,000 |
Cash Flows From Financing Activities | |||||
Debt Issued | 27,777,000 | 6,919,000 | 4,945,000 | 8,914,000 | 0 |
Debt Repayment | -1,454,000 | 0 | -4,150,000 | -6,450,000 | -4,514,000 |
Common Stock Repurchased | 0 | -6,360,000 | -4,975,000 | -3,486,000 | -7,702,000 |
Dividend Paid | -4,556,000 | -4,196,000 | -4,013,000 | -3,755,000 | -3,509,000 |
Other Financing Activity | -719,000 | -400,000 | -78,000 | -90,000 | -42,000 |
Financing Cash Flow | $21,048,000 | $-4,037,000 | $-8,271,000 | $-4,867,000 | $-15,767,000 |
Beginning Cash Position | 7,629,000 | 7,989,000 | 6,266,000 | 6,037,000 | 6,945,000 |
End Cash Position | 10,944,000 | 7,629,000 | 7,989,000 | 6,266,000 | 6,037,000 |
Net Cash Flow | $3,315,000 | $-360,000 | $1,723,000 | $229,000 | $-908,000 |
Free Cash Flow | |||||
Operating Cash Flow | 8,471,000 | 9,721,000 | 9,261,000 | 10,497,000 | 9,150,000 |
Capital Expenditure | -1,112,000 | -936,000 | -880,000 | -608,000 | -618,000 |
Free Cash Flow | 7,359,000 | 8,785,000 | 8,381,000 | 9,889,000 | 8,532,000 |